Trial
NCT03965091
A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With Fibromyalgia
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Collaborators
—
Condition
Fibromyalgia
Intervention
Fremanezumab
Why stopped
Met pre-specified criteria for futility at interim analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-03-30